Back
China Sxt Pharmaceuticals, Inc. 10K Form
Sell
38
SXTC
China Sxt Pharmaceuticals, Inc.
Last Price:
$1.37
Seasonality Move:
24.22%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SXTC News And Ratings
See the #1 stock for the next 7 days that we like better than SXTC
SXTC Financial Statistics
Sales & Book Value
| Annual Sales: | $1.7M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.28 |
| Price / Book: | 48.72 |
Profitability
| EPS (TTM): | -16.36570 |
|---|---|
| Net Income (TTM): | $-3.1M |
| Gross Margin: | $367.4K |
| Return on Equity: | -27.59% |
| Return on Assets: | -13.82% |
China Sxt Pharmaceuticals, Inc. Earnings Forecast
Key China Sxt Pharmaceuticals, Inc. Financial Ratios
-
The Gross Profit Margin over the past 10 years for SXTC is 21.10%.
-
The Selling, General & Administrative Expenses for SXTC have been equal to 175.08% of Gross Profit Margin.
-
The Research & Development expenses have been 10.99% of Revenue.
-
The Net Earning history of SXTC is -189.77% of Total Revenues.
-
Per Share Earnings over the last 10 years have been positive in 5 years.
China Sxt Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | SXTC |
| CUSIP: | G2161P |
| Website: | sxtchina.com |
Debt
| Debt-to-Equity Ratio: | 0.17 |
|---|---|
| Current Ratio: | 1.6 |
| Quick Ratio: | 1.51 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SXTC Technical Analysis vs Fundamental Analysis
Sell
38
China Sxt Pharmaceuticals, Inc. (SXTC)
is a Sell
Is China Sxt Pharmaceuticals, Inc. a Buy or a Sell?
-
China Sxt Pharmaceuticals, Inc. stock is rated a SellThe current China Sxt Pharmaceuticals, Inc. [SXTC] share price is $1.38. The Score for SXTC is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.